These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 2872237)

  • 21. Tardive dyskinesia in patients receiving lithium maintenance therapy.
    Perényi A; Szücs R; Frecska E
    Biol Psychiatry; 1984 Nov; 19(11):1573-8. PubMed ID: 6151403
    [No Abstract]   [Full Text] [Related]  

  • 22. Serum neuroleptic levels and extrapyramidal side effects in patients treated with amoxapine.
    Gaffney GR; Tune LE
    J Clin Psychiatry; 1985 Oct; 46(10):428-9. PubMed ID: 2864332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe neurotoxicity and lithium therapy.
    Pi HT; Surawicz FG
    Clin Toxicol; 1978; 13(4):479-86. PubMed ID: 747906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lithium and neuroleptics in combination: the spectrum of neurotoxicity [corrected].
    Goldman SA
    Psychopharmacol Bull; 1996; 32(3):299-309. PubMed ID: 8961772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of antipsychotic drugs and lithium in mania.
    Cookson J
    Br J Psychiatry Suppl; 2001 Jun; 41():s148-56. PubMed ID: 11450176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of neuroleptics in manic-depressive illness.
    Kane JM
    J Clin Psychiatry; 1988 Nov; 49 Suppl():12-4. PubMed ID: 2903142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurologic complications in patients treated with lithium.
    Kiejna A; Krakiewicz A
    Psychiatr J Univ Ott; 1988 Sep; 13(3):164-6. PubMed ID: 3054982
    [No Abstract]   [Full Text] [Related]  

  • 28. The syndrome of irreversible lithium-effectuated neurotoxicity (SILENT).
    Adityanjee
    Pharmacopsychiatry; 1989 Mar; 22(2):81-3. PubMed ID: 2717661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
    Prescrire Int; 2005 Aug; 14(78):140-2. PubMed ID: 16106596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversible neurotoxicity induced by a combination of clozapine and lithium: a case report.
    Lee SH; Yang YY
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Mar; 62(3):184-7. PubMed ID: 10222608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antipsychotics in bipolar disorder.
    Gelenberg AJ; Hopkins HS
    J Clin Psychiatry; 1996; 57 Suppl 9():49-52. PubMed ID: 8823350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is there a role for neuroleptics in bipolar depression?
    Hendrick V; Altshuler LL; Szuba MP
    J Clin Psychiatry; 1994 Dec; 55(12):533-5. PubMed ID: 7814347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebellar syndrome in a patient with pneumonia under lithium treatment: A case report.
    Ozsoy S; Basturk M; Esel E
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1532-4. PubMed ID: 16806624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of neuroleptic dose and neurotoxicity in patients given lithium and a neuroleptic.
    Miller F; Menninger J
    Hosp Community Psychiatry; 1987 Nov; 38(11):1219-21. PubMed ID: 2889659
    [No Abstract]   [Full Text] [Related]  

  • 35. Lithium and neuroleptic drugs in combination - effect on lithium RBC/plasma ratio.
    von Knorring L; Smigan L; Perris C; Oreland L
    Int Pharmacopsychiatry; 1982; 17(4):287-92. PubMed ID: 6136488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dangerous side effects of lithium therapy].
    Ehle G; Uebelhack R
    Psychiatr Neurol Med Psychol Beih; 1977; 22-23():177-82. PubMed ID: 233713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of the combination of lithium and neuroleptic drugs.
    Goldney RD; Spence ND
    Am J Psychiatry; 1986 Jul; 143(7):882-4. PubMed ID: 2872825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroleptic exposure in bipolar outpatients in a research setting.
    Denicoff KD; Sollinger AB; Frye MA; Ali SO; Smith-Jackson EE; Leverich GS; Post RM
    Compr Psychiatry; 2000; 41(4):248-52. PubMed ID: 10929791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of propranolol in a patient with tardive dyskinesia and extrapyramidal syndrome.
    Chaudhry R; Radonjic D; Waters B
    Am J Psychiatry; 1982 May; 139(5):674-6. PubMed ID: 6122382
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.